India, Sept. 29 -- The Surat-based specialty chemicals and contract development and manufacturing company is edging toward a full pharmaceutical value chain. On 28 September 2026, Anupam Rasayan India Limited completed a key share purchase and took charge of a listed maker of finished drugs. The step follows a solid first quarter, a recent US acquisition and a steady run of new product launches. Whether integration, funding and returns hold up over the coming quarters is the harder question, and one investors will watch.

Shares of Anupam Rasayan India Ltd are trading at Rs. 1,185.70, down 0.12 percent on Tuesday. The stock touched the intraday high of Rs. 1,196.50 after opening at Rs. 1,187.20 before slipping to a low of Rs. 1,176.10. T...